Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 14:28:06 10/09/2026 +04			5-day change	1st Jan Change
2,840.80 ^INR	-1.57%		-3.59%	+14.97%

08-03	GSK India first-quarter profit rises on steady vaccine demand	RE
08-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	5.14B	-	-	-	-
ELI LILLY AND COMPANY	1,002B		A
JOHNSON & JOHNSON	644B		BBB	-
ABBVIE INC.	443B		AAA		-
ROCHE HOLDING AG	343B		AA
NOVARTIS AG	262B		AAA
ASTRAZENECA PLC	245B		A
AMGEN INC.	212B		A
NOVO NORDISK A/S	199B		BBB
GILEAD SCIENCES, INC.	181B		AA
PFIZER INC.	158B		A
VERTEX PHARMACEUTICALS INCORPORATED	132B		AA
BRISTOL-MYERS SQUIBB COMPANY	132B		A
SANOFI	103B		A
GSK PLC	97.89B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	69.38B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.38B		AA
BAYER AG	56.24B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	43.9B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.94B		-
Average	221.45B		AA
Weighted average by Cap.			AA